Widoxil® Dry Syrup

Indication : Widoxil® is indicated for the treatment of patients with infevction caused by suspectible strains of the designated organisms in the following diseases :
Respiratory tract infections caused by Streptococcus pyogenes.
Skin and soft tissue infections caused by staphylococci and/or streptococci.
Urinary tract infections caused by E. coli, P. mirabilis, and Klebsiella sp.
Other infections : Osteomyelitis and septic arthritis.

Composition :
Each 5 ml (a measurement spoonful) Widoxil® Dry syrup 125 mg/5 ml contains Cefadroxil monohydrate equivalent to Cefadroxil anhydrate 125 mg.
Contain of excipients: Coloidal silicon dioxide, Polysorbate 80, Sodium benzoate, Tartrazine CI 19140 E102 (Dye), Orange Encapsulates, Sucrose, Xanthan Gum.

Each 5 ml (a measurement spoonful) Widoxil® Dry syrup 250 mg/5 ml contains Cefadroxil monohydrate equivalent to Cefadroxil anhydrate 250 mg.
Contain of excipients: Coloidal silicon dioxide, Polysorbate 80, Sodium benzoate, Tartrazine CI 19140 E102 (Dye), Orange Encapsulates, Sucrose, Xanthan Gum

Presentation :
Widoxil® Dry syrup 125 mg/5 ml
Box, 1 bottle @ 60 ml

Widoxil® Dry syrup 250 mg/5 ml
Box, 1 bottle @ 60 ml

On medical prescription only.
Store below 30°C, protect from light.